Opinion

Video

Cyclosporine Ophthalmic Solution for Inflammatory Dry Eye

Author(s):

Alice Epitropoulos, MD,Laura M. Periman, MD

Dry eye experts discuss Cyclosporine ophthalmic solution.

Video content above is prompted by the following question(s):

1. Cyclosporine ophthalmic solution, 0.1% (VEVYE)

Related Videos
2 experts are featured in this series.
2 experts are featured in this series.
Cochair Kelly K. Nichols, OD, PhD, MPH, FAAO, highlights her passion for dry eye research and the vital collaboration between ophthalmology and optometry
Alice Epitropoulos, MD, and Laura M. Periman, MD
Alice Epitropoulos, MD, and Laura M. Periman, MD
Alice Epitropoulos, MD, and Laura M. Periman, MD
Alice Epitropoulos, MD, and Laura M. Periman, MD
Related Content
Women advised to take part in Dry January to reduce dry eye risk
January 2nd 2025

Women advised to take part in Dry January to reduce dry eye risk

Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 4)
September 13th 2023

Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 4)

Ophthalmology Times 2024 wrap-up: A year of innovation and insight
December 26th 2024

Ophthalmology Times 2024 wrap-up: A year of innovation and insight

Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 3)
September 13th 2023

Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 3)

BostonSight publishes pilot study on PROSE scleral lenses as a drug delivery system for cyclosporine in dry eye treatment
December 6th 2024

BostonSight publishes pilot study on PROSE scleral lenses as a drug delivery system for cyclosporine in dry eye treatment

Cambium Bio completes funding to help advance dry eye disease treatment
December 5th 2024

Cambium Bio completes funding to help advance dry eye disease treatment

© 2025 MJH Life Sciences

All rights reserved.